Injectable versus mono-thread PLLA for atrophic acne scars
Official title: Poly-L-Lactic Acid: A Comparative Study of Injectable and Thread-Based Delivery in Atrophic Acne Scars
Run by Zagazig University · NCT07523217 · Data updated 2026-11-12
This trial will try two ways of using poly-L-lactic acid—injectable injections versus mono-threads—to improve atrophic acne scars in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig, Sharqia Province) |
| Status | Recruiting |
| Started | March 15, 2026 |
| Main results expected | March 15, 2027 |
| Study ends | March 15, 2027 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT07523217 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with clinically diagnosed atrophic acne scars graded 2–4 who can attend Zagazig University Hospital and do not have active acne, recent scar treatment, pregnancy/lactation, bleeding disorders, keloid tendency, systemic wound-healing diseases, or known PLLA allergy are ideal candidates.
✕Probably not a fit
Patients with active inflammatory acne, a history of keloids, systemic conditions that impair wound healing, pregnancy or lactation, or known hypersensitivity to PLLA components are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a prospective split-face design, 24 adult patients with Goodman and Baron grade 2–4 atrophic acne scars received PLLA mono-threads on the right side (single session) and injectable PLLA on the left side (two sessions six weeks apart). Clinical outcomes, dermal remodeling, and safety were followed for three months using Goodman and Baron qualitative and quantitative grading systems. The study compares effects on scar appearance, collagen stimulation, and skin physiology between the two delivery modalities. Adverse events and tolerability were monitored for each side.
Why it matters
Potential benefit: If successful, one delivery method could offer better scar improvement or longer-lasting results with an acceptable safety profile, helping patients and clinicians choose the best option.
How similar studies have gone: Previous studies show PLLA can stimulate neocollagenesis and improve atrophic acne scars, but direct head-to-head comparisons between injectable PLLA and mono-threads are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * included adult patients (≥18 years) of both sexes presenting with clinically diagnosed atrophic acne scars (Grades 2-4 according to the Goodman and Baron classification) Exclusion Criteria: * active acne lesions, pregnancy or lactation, bleeding disorders, keloid tendency, systemic diseases affecting wound healing, recent acne scar treatment within the past six months, and known hypersensitivity to PLLA components.
Where it's running
-
Zagazig University Hospitals
Zagazig, Sharqia Province, Egypt Recruiting
Study contacts
- Study coordinator: Reham Essam, MD
- Email: rereessam22@gmail.com
- Phone: +201097709477
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Modified TLIP vs Retrolaminar block for pain after two-level lumbar spine surgery
This randomized trial tests whether the modified TLIP block provides better early pain control and less opioid use than the retrolaminar block after two-level lumbar spine surgery, in adults aged 21–65.
-
Pain relief for high-risk children after anorectal and penile surgery using a targeted nerve block
This study tests whether ultrasound-guided sacral multifidus plane blocks can provide safe, effective pain relief for high-risk pediatric patients undergoing anorectal and penile surgeries.
-
Eradicating Helicobacter pylori in adults with COPD
This project will try whether getting rid of H. pylori helps adults with COPD have fewer respiratory problems or less inflammation.
-
Exosome injections to improve atrophic facial scars
This trial will test whether injecting exosomes into atrophic facial scars improves their appearance and texture compared with saline injections in adults with multiple facial scars.
-
Intradermal exosomes, platelet-rich plasma, and steroid injections for post-herpetic neuralgia
This study will test whether intradermal injections of exosomes, platelet-rich plasma (PRP), or a steroid can lessen long-lasting shingles-related nerve pain in adults.
-
LarySeal Clear versus Ambu Aura40 airway masks for preschool children
This test will see if the LarySeal Clear or the Ambu Aura40 laryngeal mask works better for keeping a secure airway in preschool children having short general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.